Top 10s Current Top 10 by F1000 Factor All Time Top 10 by F1000 Factor Most viewed Top 10 (from all journals) Most viewed Top 10 (from specialty journals) Hidden Jewels Sections Covered Cerebrovascular Disease
Cognitive Neurology & Dementia
Developmental & Pediatric Neurology
Epilepsy
Headache
Infectious Diseases of the Nervous System
Movement Disorders
Multiple Sclerosis & Related Disorders
Neuro-Oncology
Neuro-Ophthalmology & Neuro-Otology
Neurogenetics
Neuroimaging
Neuromuscular Diseases
Neurorehabilitation & CNS Trauma
Peripheral Neuropathies
Related Sections Alzheimer's Disease
Disorders of Neurogastroenterology & Motility
Neuro-Endocrinology & Pituitary
Neurological Problems in Critical Care
Neuropsychiatric Disorders
Pain Management: Acute Clinical
Pain Management: Chronic Clinical
Pain: Basic Science
Schizophrenia & Other Psychoses
1
2
3
4
5
6
Must Read
F1000 Factor 6.0
New Finding
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Segal BM, Constantinescu CS, …, Kasper LH, Ustekinumab MS InvestigatorsLancet Neurol 2008 Sep 7 (9):796-804
[abstract on PubMed ]
[related articles ]
[full text ]
[order article ]
Selected by |
Roland Martin
with
Manuel Friese
Evaluated 14 Nov 2008
7
8
9
10